The FDA approved a medication to treat patients with high cholesterol who have had no success with current treatment options.
As many as one in ten hospitalized children are impacted by a medication error, and up to 35% of these errors are serious or life threatening. The challenge is to learn from these events and to adopt effective strategies to prevent harmful errors from happening again. Based on the results of a recent Institute for Safe Medication Practices survey, it appears that we still have a long way to go to meet that challenge. The survey results make it clear that more needs to be done to protect pediatric patients from harmful medication errors.